Genetics of pheochromocytoma and paraganglioma in Spanish patients.

The presence of familial history in pheochromocytoma/paraganglioma patients, including syndromic antecedents, leads in the majority of cases to a positive genetic testing for mutations in one of the major susceptibility genes described so far. Furthermore, it has been reported that in the absence of...

Full description

Bibliographic Details
Authors: Cascon Soriano, Alberto, Pita, Guillermo, Burnichon, Nelly, Landa, Iñigo, López-Jiménez, Elena, Montero-Conde, Cristina, Leskelä, Susanna, Leandro-García, Luis Javier, Letón, Rocío, Rodríguez-Antona, Cristina, Díaz, José Angel, López-Vidriero, Emilio, González-Neira, Anna, Velasco, Ana, Matias-Guiu, Xavier, Gimenez-Roqueplo, Anne-Paule, Robledo Batanero, Mercedes
Format: article
Publication Date:2009
Country:España
Institution:Instituto de Salud Carlos III (ISCIII)
Repository:Repisalud
Language:English
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/26073
Online Access:https://hdl.handle.net/20.500.12105/26073
Access Level:Open access
Keyword:MATERNAL TRANSMISSION
CLINICAL PRESENTATION
NECK PARAGANGLIOMA
SDHD MUTATION
PREVALENCE
HEAD
Description
Summary:The presence of familial history in pheochromocytoma/paraganglioma patients, including syndromic antecedents, leads in the majority of cases to a positive genetic testing for mutations in one of the major susceptibility genes described so far. Furthermore, it has been reported that in the absence of familial antecedents, about 11-24% of patients also carry a mutation in one of these related genes. In these cases, other clinical aspects like bilaterality, multiplicity, location of the tumors, or age at onset can help to recognize the underlying genes involved.